Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to address regional disparities in thyroid treatment, particularly variations in prescribing liothyronine between different integrated care boards.

Integrated care boards (ICBs) are responsible for supporting appropriate prescribing in their areas, taking account of this guidance and individual clinical circumstances.

National Health Service regions cascaded the Items which should not be routinely prescribed in primary care policy guidance, which includes a reference to liothyronine, to ICBs.